Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus 0.2% for Acanthosis Nigricans
NCT06940895Phase 2Completed
- Sponsor
- Narrows Institute for Biomedical Research
- Start
- Mar 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in acanthosis nigricans, sponsored by Narrows Institute for Biomedical Research. Started Mar 2025; status: completed.
02
Drugs
sirolimus
03
Conditions
acanthosis nigricans
Beyond the preview
Go deeper on NCT06940895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06940895.